A method of forming a multi-particulate dosage form using rotary granulation is described in which polyethylene oxide is employed as s binder in a rotary granulation process. A multi-particulate oral dosage form comprises a plurality of pellets, the pellets comprising a core having disposed thereon a core composition layer. The core composition layer comprises venlafaxine and a binder, wherein the binder comprises a polyethylene oxide. In other embodiments, the binder comprises a 1:2:1 bis (butyl methacrylate-co-(2-dimethylaminoethyl)methacrylate-co-methyl methacrylate.

 
Web www.patentalert.com

< Uses of 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRIS

< Treatment modalities for autoimmune diseases

> 3-.beta.-D-ribofuranosylthiazolo[4,5-d]pyrimidine nucleosides and uses thereof

> Substituted thieno[3,2-D]pyrimidines as non-basic melanin concentrating hormone receptor-1 antagonists

~ 00621